Patents by Inventor Christophe Rochais

Christophe Rochais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Donecopride As Neuroprotective Agent In the Treatment of Neurodegenerative Diseases
    Publication number: 20220031680
    Abstract: A compound of formula (I) for use as neuroprotective agent in the prevention and/or treatment of a neurodegenerative disease.
    Type: Application
    Filed: September 27, 2019
    Publication date: February 3, 2022
    Inventors: Patrick Dallemagne, Christophe Rochais, Sylvie Claeysen
  • Derivatives of m-Guaiacol, Their Preparation and Their Uses
    Publication number: 20210337789
    Abstract: The invention concerns derivatives of m-guaiacol, their preparation and their uses as biocides, in particular as antibacterials or disinfectants.
    Type: Application
    Filed: July 2, 2019
    Publication date: November 4, 2021
    Applicants: Universite de Caen Normandie, LABEO
    Inventors: Sylvain Rault, Christophe Rochais, Stéphane Lemaitre, Feng Xiao, Peggy Suzanne, Patrick Dallemagne, Sophie Castagnet, Albertine Leon-Seck
  • Combination of Acetylcholinesterase Inhibitor and 5-HT4 Receptor Agonist As Neuroprotective Agent In the Treatment of Neurodegenerative Diseases
    Publication number: 20210338647
    Abstract: A pharmaceutical composition including an acetylcholinesterase inhibitor and a 5-HT4 receptor agonist, for use as neuroprotective agent in the prevention and/or treatment of a neurodegenerative disease; and a neuroprotective pharmaceutical combination including an acetylcholinesterase inhibitor and a 5-HT4 receptor agonist for simultaneous, separate or sequential use as neuroprotective agent in the prevention and/or treatment of a neurodegenerative disease.
    Type: Application
    Filed: September 27, 2019
    Publication date: November 4, 2021
    Inventors: Patrick Dallemagne, Christophe Rochais, Sylvie Claeysen
  • Bambuterol for the Treatment of Alzheimer's Disease
    Publication number: 20210121432
    Abstract: Bambuterol for the Treatment of Alzheimer's Disease Bambuterol or the pharmaceutically acceptable salt thereof is used in an effective amount to treat Alzheimer's disease. The compound is administered intranasal, or through oral or intravenous routes and under an appropriate formulation for getting around the blood brain barrier, wherein it may do one more of preventing, slowing the progression of, or reversing Alzheimer's disease.
    Type: Application
    Filed: April 16, 2019
    Publication date: April 29, 2021
    Applicant: Université de Caen Normandie
    Inventors: Christophe ROCHAIS, Patrick DALLEMAGNE, Anne-Claire GROO, Aurélie MALZERT-FRÉON
  • Acetylcholinesterase inhibitors and promnesiant serotonin 5-HT4 receptor agonists, their methods of preparation and the pharmaceutical compositions containing the same
    Patent number: 9663465
    Abstract: Compounds are provided according to Formula (I) as well as their enantiomers and their racemics, their acid salts, their hydrates or their solvation products. Among a large number of possible meanings, X represents a halogen, Y an oxygen atom; all of the coefficients m, n, r and s have the value 1, R represents an ethyl and R? a cycloalkyl. The invention also includes Methods of preparing the above compounds and the pharmaceutical compositions containing them also are provided.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: May 30, 2017
    Assignee: UNIVERSITE DE CAEN
    Inventors: Patrick Dallemagne, Christophe Rochais, Cedric Lecoutey, Michel Boulouard, Thomas Freret
  • ACETYLCHOLINESTERASE INHIBITOR COMPOUNDS AND 5HT4 SEROTONERGIC RECEPTOR AGONISTS, WITH PROMNSIA EFFECT, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
    Publication number: 20160122300
    Abstract: Compounds are provided according to Formula (I) as well as their enantiomers and their racemics, their acid salts, their hydrates or their solvation products. Among a large number of possible meanings, X represents a halogen, Y an oxygen atom; all of the coefficients m, n, r and s have the value 1, R represents an ethyl and R? a cycloalkyl. The invention also includes Methods of preparing the above compounds and the pharmaceutical compositions containing them also are provided.
    Type: Application
    Filed: May 19, 2014
    Publication date: May 5, 2016
    Inventors: Patrick Dallemagne, Christophe Rochais, Cedric Lecoutey, Michel Boulouard, Thomas Freret